Tuesday, August 11, 2009

Ranbaxy gets US FDA approval for Sumatriptan Succinate tabs

Ranbaxy Laboratories has received final approval from the US FDA to manufacture and market Sumatriptan Succinate tablets 25 mg, and 50 mg. These tablets are the generic equivalent of GlaxoSmithKline's Imitrex tablets.

The details can be read here.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)